Multiple Sclerosis Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with relapsing-remitting multiple sclerosis (a form of MS with flare-ups and periods of recovery) or another type of MS, confirmed by standard neurological assessment.
- People who are able to undergo a type of eye scan called OCTA imaging and a vision test called visual field testing.
- People who have enough vision to complete visual field testing in a reliable way.
- People who do not have any other eye conditions that affect the retina or the optic nerve (such as diabetic retinopathy or glaucoma).
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have eye conditions unrelated to MS that could affect the results of OCTA imaging or visual field testing.
- People who have had an episode of optic neuritis (inflammation of the optic nerve) recently — typically within the past 3 to 6 months — as this could affect results (confirm with trial site).
- People who have cloudiness or other problems inside the eye that would prevent a clear OCTA scan from being taken.
- People who have certain health conditions that can affect the blood vessels in the retina, such as uncontrolled high blood pressure or diabetes.
- People who are unable to cooperate or complete visual field testing in a reliable way.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +0201124142020
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
1-To evaluate the correlation between OCTA-derived microvascular metrics {Structural measure} and visual field defects{Functional measure} in patients with multiple sclerosis (MS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.